Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of action of ciclesonide in asthma
NCT00546520Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2002
- Primary completion
- Jun 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ciclesonide in asthma (3 arms), sponsored by AstraZeneca. Primary endpoint: Provocative Concentration of AMP causing a 20% fall in FEV1 at 7 days. Started Apr 2002; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00546520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546520.